National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2017 (No 2) (PB 43 of 2017) (Cth)

PB 43 of 2017

National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2017 (No. 2)

National Health Act 1953

I, JULIANNE QUAINE, as delegate of the Minister for Health and Aged Care, make this Instrument under subsections 100(2) of the National Health Act 1953.

Dated         31 May 2017

JULIANNE QUAINE

Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

1       Name of Instrument

(1)This Instrument is the National Health (Paraplegic and Quadriplegic Program) Special Arrangement Amendment Instrument 2017 (No 2).

(2)This Instrument may also be cited as PB 43 of 2017.

2Commencement

This Instrument commences on 1 June 2017.

3       Amendments to National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010

Schedule 1 amends the National Health (Paraplegic and Quadriplegic Program) Special Arrangement 2010 (PB 118 of 2010).

Schedule 1     Amendments

[1]           Schedule 1, entry for Bisacodyl:

Omit from the column headed ‘Responsible Person’ for the brand Dulcolax: BY     substitute: VZ

[2]           Schedule 2

Omit:

BY Beohringer Ingelheim Pty Ltd 52 000 452 308

Insert, after entry for AE:

VZ Sanofi-Aventis Australia Pty Ltd 31 008 558 807